|
1
|
Yang J and Moses MA: Lipocalin 2: A
multifaceted modulator of human cancer. Cell Cycle. 8:2347–2352.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Xu S and Venge P: Lipocalins as
biochemical markers of disease. Biochim Biophys Acta. 1482:298–307.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Alpízar-Alpízar W, Laerum OD, Illemann M,
Ramírez JA, Arias A, Malespín-Bendaña W, Ramírez V, Lund LR,
Borregaard N and Nielsen BS: Neutrophil gelatinase-associated
lipocalin (NGAL/Lcn2) is upregulated in gastric mucosa infected
with Helicobacter pylori. Virchows Arch. 455:225–233. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yan L, Borregaard N, Kjeldsen L and Moses
MA: The high molecular weight urinary matrix metalloproteinase
(MMP) activity is a complex of gelatinase B/MMP-9 and neutrophil
gelatinase-associated lipocalin (NGAL). Modulation of MMP-9
activity by NGAL. J Biol Chem. 276:37258–37265. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tschesche H, Zölzer V, Triebel S and
Bartsch S: The human neutrophil lipocalin supports the allosteric
activation of matrix metalloproteinases. Eur J Biochem.
268:1918–1928. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sier CF, Kubben FJ, Ganesh S, Heerding MM,
Griffioen G, Hanemaaijer R, van Krieken JH, Lamers CB and Verspaget
HW: Tissue levels of matrix metalloproteinases MMP-2 and MMP-9 are
related to the overall survival of patients with gastric carcinoma.
Br J Cancer. 74:413–417. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kubben FJ, Sier CF, van Duijn W, Griffioen
G, Hanemaaijer R, van de Velde CJ, van Krieken JH, Lamers CB and
Verspaget HW: Matrix metalloproteinase-2 is a consistent prognostic
factor in gastric cancer. Br J Cancer. 94:1035–1040. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Matsumura S, Oue N, Nakayama H, Kitadai Y,
Yoshida K, Yamaguchi Y, Imai K, Nakachi K, Matsusaki K, Chayama K,
et al: A single nucleotide polymorphism in the MMP-9 promoter
affects tumor progression and invasive phenotype of gastric cancer.
J Cancer Res Clin Oncol. 131:19–25. 2005. View Article : Google Scholar
|
|
9
|
Kjeldsen L, Johnsen AH, Sengeløv H and
Borregaard N: Isolation and primary structure of NGAL, a novel
protein associated with human neutrophil gelatinase. J Biol Chem.
268:10425–10432. 1993.PubMed/NCBI
|
|
10
|
Nuntagowat C, Leelawat K and Tohtong R:
NGAL knockdown by siRNA in human cholangiocarcinoma cells
suppressed invasion by reducing NGAL/MMP-9 complex formation. Clin
Exp Metastasis. 27:295–305. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Fernández CA, Yan L, Louis G, Yang J,
Kutok JL and Moses MA: The matrix metalloproteinase-9/neutrophil
gelatinase-associated lipocalin complex plays a role in breast
tumor growth and is present in the urine of breast cancer patients.
Clin Cancer Res. 11:5390–5395. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Leng X, Ding T, Lin H, Wang Y, Hu L, Hu J,
Feig B, Zhang W, Pusztai L, Symmans WF, et al: Inhibition of
lipocalin 2 impairs breast tumorigenesis and metastasis. Cancer
Res. 69:8579–8584. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kubben FJ, Sier CF, Hawinkels LJ,
Tschesche H, van Duijn W, Zuidwijk K, van der Reijden JJ,
Hanemaaijer R, Griffioen G, Lamers CB, et al: Clinical evidence for
a protective role of lipocalin-2 against MMP-9 autodegradation and
the impact for gastric cancer. Eur J Cancer. 43:1869–1876. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yang SH, Kim JS, Oh TJ, Kim MS, Lee SW,
Woo SK, Cho HS, Choi YH, Kim YH, Rha SY, et al: Genome-scale
analysis of resveratrol-induced gene expression profile in human
ovarian cancer cells using a cDNA microarray. Int J Oncol.
22:741–750. 2003.PubMed/NCBI
|
|
15
|
Parkin DM, Bray FI and Devesa SS: Cancer
burden in the year 2000. The global picture. Eur J Cancer. 37(Suppl
8): S4–S66. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Nielsen BS, Borregaard N, Bundgaard JR,
Timshel S, Sehested M and Kjeldsen L: Induction of NGAL synthesis
in epithelial cells of human colorectal neoplasia and inflammatory
bowel diseases. Gut. 38:414–420. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Rudd PM, Mattu TS, Masure S, Bratt T, Van
den Steen PE, Wormald MR, Küster B, Harvey DJ, Borregaard N, Van
Damme J, et al: Glycosylation of natural human neutrophil
gelatinase B and neutrophil gelatinase B-associated lipocalin.
Biochemistry. 38:13937–13950. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li SH, Hawthorne VS, Neal CL, Sanghera S,
Xu J, Yang J, Guo H, Steeg PS and Yu D: Upregulation of neutrophil
gelatinase-associated lipocalin by ErbB2 through nuclear
factor-kappaB activation. Cancer Res. 69:9163–9168. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liu Q and Nilsen-Hamilton M:
Identification of a new acute phase protein. J Biol Chem.
270:22565–22570. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Liu Q, Nilsen-Hamilton M and Xiong S:
Synergistic regulation of the acute phase protein SIP24/24p3 by
glucocorticoid and pro-inflammatory cytokines. Sheng Li Xue Bao.
55:525–529. 2003.PubMed/NCBI
|
|
22
|
Bauer M, Eickhoff JC, Gould MN, Mundhenke
C, Maass N and Friedl A: Neutrophil gelatinase-associated lipocalin
(NGAL) is a predictor of poor prognosis in human primary breast
cancer. Breast Cancer Res Treat. 108:389–397. 2008. View Article : Google Scholar
|
|
23
|
Tong Z, Kunnumakkara AB, Wang H, Matsuo Y,
Diagaradjane P, Harikumar KB, Ramachandran V, Sung B, Chakraborty
A, Bresalier RS, et al: Neutrophil gelatinase-associated lipocalin:
A novel suppressor of invasion and angiogenesis in pancreatic
cancer. Cancer Res. 68:6100–6108. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Viau A, El Karoui K, Laouari D, Burtin M,
Nguyen C, Mori K, Pillebout E, Berger T, Mak TW, Knebelmann B, et
al: Lipocalin 2 is essential for chronic kidney disease progression
in mice and humans. J Clin Invest. 120:4065–4076. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Jiang W, Constante M and Santos MM: Anemia
upregulates lipocalin 2 in the liver and serum. Blood Cells Mol
Dis. 41:169–174. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Greten FR, Eckmann L, Greten TF, Park JM,
Li ZW, Egan LJ, Kagnoff MF and Karin M: IKKbeta links inflammation
and tumorigenesis in a mouse model of colitis-associated cancer.
Cell. 118:285–296. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Li C and Chan YR: Lipocalin 2 regulation
and its complex role in inflammation and cancer. Cytokine.
56:435–441. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Leng X, Wu Y and Arlinghaus RB:
Relationships of lipocalin 2 with breast tumorigenesis and
metastasis. J Cell Physiol. 226:309–314. 2011. View Article : Google Scholar
|
|
29
|
Hanai J, Mammoto T, Seth P, Mori K,
Karumanchi SA, Barasch J and Sukhatme VP: Lipocalin 2 diminishes
invasiveness and metastasis of Ras-transformed cells. J Biol Chem.
280:13641–13647. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lee HJ, Lee EK, Lee KJ, Hong SW, Yoon Y
and Kim JS: Ectopic expression of neutrophil gelatinase-associated
lipocalin suppresses the invasion and liver metastasis of colon
cancer cells. Int J Cancer. 118:2490–2497. 2006. View Article : Google Scholar
|
|
31
|
Zhang H, Xu L, Xiao D, Xie J, Zeng H, Wang
Z, Zhang X, Niu Y, Shen Z, Shen J, et al: Upregulation of
neutrophil gelatinase-associated lipocalin in oesophageal squamous
cell carcinoma: Significant correlation with cell differentiation
and tumour invasion. J Clin Pathol. 60:555–561. 2007. View Article : Google Scholar : PubMed/NCBI
|
